Search results
A Phase 2 open-label study in patients with recurrent Genotype 1 hepAtitis C post orthotopic Liver transplAnt to eXplore the safety and efficacY of simeprevir and sofosbuvir with and without ribavirin
… of the liver) C virus (HCV) Genotype 1 infection. Trial Website: https://clinicaltrials.gov/show/NCT02165189 …
Last Modified:
An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C infection
… may be added at the discretion of the investigator. Trial Website: https://clinicaltrials.gov/show/NCT01779518 …
Last Modified:
A Study to Evaluate Chronic Hepatitis C Infection in Adult Liver Transplant Recipients
… to evaluate chronic Hepatitis C Virus infection. Trial Website: https://clinicaltrials.gov/show/NCT01782495 …
Last Modified:
A Phase II Randomized Multicenter Placebo- Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)
… high risk patients following liver transplantation. Trial Website: https://clinicaltrials.gov/show/NCT01624285 …
Last Modified:
InTeam: Integrated approaches for identifying molecular targets in alcoholic hepatitis
… with diagnosis, severity of disease and survival. Trial Website: https://clinicaltrials.gov/show/NCT02075918 …
Last Modified:
Patient Stories
… worsening — without a new liver, she would eventually die. Read the full story here » "Thank you a thousand times …
Last Modified:
Aortic Aneurysm Surgery
… an average of 3% of patients undergoing elective surgery die, and during emergency surgery, the rate of death is 13%. …
Last Modified:
Non-Cancerous Breast Disease
… when the cells don’t turn into scar tissue, but instead die and release their contents. Symptoms of fat necrosis and …
Last Modified:
Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
… Double-Blind Phase Open Label Phase (optional) Trial Website: https://clinicaltrials.gov/show/NCT01672879 …
Last Modified: